United Therapeutics files patent infringement lawsuit against Sandoz
The suit is based on an ANDA filed by Sandoz seeling approval to market a generic version of the 10mg/mL strength of Remodulin. Sandoz’s ANDA alleges that the
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.
The expansion features approximately 49,000ft² of distribution space and 8,000ft² of packaging space. The existing campus will continue to facilitate the administrative offices, sales, marketing and distribution functions
Mylan-Rosuvastatin is the generic version of Astra Zeneca’s Crestor Tablets, which are used for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia. Rosuvastatin Calcium Tablets, 5mg,